Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
1849 E. 1450 Rd. , Lawrence, KS, 66044, US
CritiTech is a multi-service CDMO specializing in pre-formulation, formulation, particle engineering, analytical methods and testing, and preclinical to GMP manufacturing. We use spray drying, jet milling and our proprietary Purcision platform to engineer non-cyto, cyto, potent, and inhaled drugs. CritiTech produces fast, impactful and quality results.
Łukasiewicz, known for advanced chemical synthesis and production scaling capabilities, will help ExploRNA ramp up its mRNA manufacturing.
By: Patrick Lavery
North American expansion strengthens CDMO support for medtech and healthcare packaging.
By: Charlie Sternberg
The designation applies to the site’s BCM3 antibody intermediate and conjugated drug substance dual-function production line, and DP4 facility.
The 85,000-sq.-ft. East Norriton site adds GMP cleanrooms, fill-finish capacity, and immediate onboarding for cell therapy sponsors.
The CDMO collaboration will combine Bespak’s nasal device portfolio with Upperton’s formulation, analytical and clinical manufacturing expertise.
New advanced therapies CDMO combines immune-cell, stem-cell and mRNA-enabled capabilities across three U.S. sites.
License variation supports early-phase GMP manufacture at Nottingham facility.
Large stainless-steel projects are rising, but pipeline demand is increasingly moving toward smaller, more flexible manufacturing models.
By: Dan Stanton
Small Molecules. ADCs. Nucleic Acid Chemistry.
Released By Cohance Lifesciences
The Lüleburgaz facility adds major production capacity, technical expertise, and international client reach.
Former GSK, AstraZeneca and CDMO executive joins to support international growth.
The CDMO is adding new property, aseptic fill-finish lines, packaging capacity, and analytical capabilities at its Caponago site near Milan.
Highly potent compounds are reshaping CDMO expectations, from early risk assessment to closed, automated containment facilities.
The 3,500-square-meter BIO CITY III facility adds up to 20 cGMP manufacturing lines for cell therapies and personalized medicine.
By: Tim Wright
Deal expands PerkinElmer’s automation, GMP IT and digital manufacturing capabilities for life sciences customers.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
